Bronchioalveolar lavage with perfluorochemical liquid during conventional ventilation

Pediatric Critical Care Medicine

Volumn 8, Issue 5, 2007, Pages 486-488

  Lindemann, Rolf ^a   Rajka, Thomas ^a   Henrichsen, Thore ^a   Vinorum, Ole Georg ^a,b   De Lange, Charlotte ^a,c   Erichsen, Aage ^a   Fugelseth, Drude ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b SSHF   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bronchioalveolar lavage; Extracorporeal membrane oxygenation; Newborn; Niemann Pick disease; Perfluorochemical liquids

Indexed keywords

PERFLUORO COMPOUND; SODIUM CHLORIDE; SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; INFANT; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LUNG MECHANICS; MALE; OPEN LUNG BIOPSY; PRIORITY JOURNAL; RESPIRATORY FAILURE; TREATMENT RESPONSE;

BRONCHOALVEOLAR LAVAGE; COMBINED MODALITY THERAPY; EXTRACORPOREAL MEMBRANE OXYGENATION; FATAL OUTCOME; FLUOROCARBONS; HUMANS; INFANT; LIQUID VENTILATION; MALE; NIEMANN-PICK DISEASE, TYPE C; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY;

EID: 34548702865     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000282757.25347.6C     Document Type: Article

References (26)

1. Nogee LM, deMello DE, Dehner LP, et al: Deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993; 328:406-410
2. deMello DE, Nogee LM, Heyman S, et al: Molecular and phenotypic variability in the congenital alveolar proteinosis syndrome associated with inherited surfactant protein B deficiency. J Pediatr 1994; 125:43-50
3. Schofer O, Mischo B, Püschel W, et al: Early-lethal pulmonary form of Niemann-Pick type C disease belonging to a second, rare genetic complementation group. Eur J Pediatr 1998; 157:45-49
4. Uyan ZS, Karadaǧ B, Ersu R, et al: Early pulmonal involvement in Niemann-Pick type B disease: Lung lavage is not useful. Pediatr Pulmonol 2005; 40:169-172
5. Mahut B, De Blic J, Le Bourgeois M, et al: Partial and massive lung lavage in an infant with severe pulmonary alveolar proteinosis. Pediatr Pulmonol 1992; 13:50-53
6. Hiratzka LF, Swan DM, Rose EF, et al: Bilateral simultaneous lung lavage utilizing membrane oxygenator for pulmonary alveolar proteinosis in an 8-month-old infant. Ann Thorac Surg 1983; 35:313-317
7. Tsai WC, Lewis D, Nasr SZ, et al: Liquid ventilation in an infant with pulmonary alveolar proteinosis. Pediatr Pulmonol 1998; 26:283-286
8. Hamvas A, Cole FS, deMello DE, et al: Surfactant protein B deficiency: Antenatal diagnosis and prospective treatment with surfactant replacement. J Pediatr 1994; 125: 356-361
9. Nagasaka Y, Takahashi M, Ueshima H, et al: Bronchioalveolar lavage with trypsin in pulmonary alveolar proteinosis. Thorax 1996; 51:769-770
10. Diaz JP, Manresa Presas F, Benasco C, et al: Response to surfactant activator (ambroxol) in alveolar proteinosis. Lancet 1984; 1:1023
11. Gauger PG, Pranikoff T, Schreiner RJ, et al: Initial experience with partial liquid ventilation in pediatric patients with acute respiratory distress syndrome. Crit Care Med 1996; 24:16-22
12. Leach CL, Greenspan JS, Rubenstein SD, et al: Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome: A pilot safety and efficacy study. N Engl J Med 1996; 335:761-767
13. Shaffer TH, Wolfson MR, Clark LC Jr: Liquid ventilation. Pediatr Pulmonol 1992; 14: 102-109
14. Nakstad B, Wolfson MR, Aspelin T, et al: Perfluorochemical liquids do not stimulate endothelin-1 or nitric oxide production in human blood leukocytes. Biol Neonate 2001; 80:267-272
15. Gross GW, Greenspan JS, Fox WW, et al: Use of liquid ventilation with perflubron during extracorporeal membrane oxygenation: Chest radiographic appearances. Radiology 1995; 194:717-720
16. Wolfson MR, Shaffer TH: Pulmonary applications of perfluorochemical (PFC) liquids: Ventilation and beyond. Paediatr Respir Rev 2005; 117:117-127
17. Rotta AT, Viana MEG, Wiryawan B, et al: Combining lung-protective strategies in Experimental acute lung injury: The impact of high-frequency partial liquid ventilation. Pediatr Crit Care Med 2006; 7:562-570
18. Shaffer TH, Lowe CA, Bhutani VK, et al: Liquid ventilation: Effects on pulmonary function in distressed meconium-stained lambs. Pediatr Res 1984; 18:47-52
19. Richman PS, Wolfson MR, Shaffer TH: Lung lavage with oxygenated perfluorochemical liquid in acute lung injury. Crit Care Med 1993; 21:768-774
20. Schlösser RL, Veldman A, Fischer D, et al: Comparison of effects of perflubron and surfactant lavage on pulmonary gas exchange in a piglet model of meconium aspiration. Biol Neonate 2002; 81:126-131
21. Steinhorn DM, Leach CL, Fuhrman BP, et al: Partial liquid ventilation enhances surfactant phospholipid production. Crit Care Med 1996; 24:1252-1256
22. Shaffer TH, Greenspan JS, Wolfson MR: Liquid ventilation. In: New therapies for neonatal respiratory failure. A physiological approach. Boytyon BR, Carlo WA, Jobe AH (Eds). New York, Cambridge University Press, 1994, pp 279-301
23. Shashikant BN, Miller TL, Jeng M-J, et al: Diffeential impact of perfluorochemical physical properties on the physiologic, histologic, and inflammatory profile in acute lung injury. Crit Care Med 2005; 33: 1096-1103
24. Albafouille V, Sayegh N, De Coudenhove S, et al: CT scan patterns of pulmonary alveolar proteinosis in children. Pediatr Radiol 1999; 29:147-152
25. Fox WW, Cox CA, Weis CM, et al: Comparison of perfluorochemical fluids used for liquid ventilation: Effect of endotracheal tube flow resistance. Pediatr Pulmonol 1997; 23: 449-456
26. Miller TF, Milestone B, Stern R, et al: Effects of perfluorochemical distribution and elimination dyanamics on cardiopulmonary function. J Appl Physiol 2001; 90:839-849